Association Française Pour La Prévention Des Allergies

What Association Française Pour La Prévention Des Allergies does

AFPRAL (Association Française Pour La Prévention Des Allergies) is a French non-profit patient association (association loi 1901) headquartered at 4 Place Louis Armand, Tour d'Horloge, 75012 Paris. It is dedicated to allergy prevention, awareness, information, and patient support in France, and holds national recognition from the French Ministry of Health (Ministère de la santé et de l'accès aux Soins). The association addresses a large underlying patient population — 18 million French citizens are affected by allergies, 80% of asthmas are of allergic origin, 8% of children have food allergies, and approximately 50,000 PAI (Projet d'Accueil Individualisé) school inclusion documents are signed annually.

The association's portfolio centers on the "Distingué par l'AFPRAL" product and service certification program, the Allergie Le Mag magazine publication, therapeutic education services for schools, businesses, and the general public, the European "Beyond the Label" ERASMUS+ youth exchange program with partners in Spain, Sweden, and Italy, national allergy surveys, and informational webinars. Its digital infrastructure runs on the AssoConnect association management platform, and it maintains active presence on Facebook, Twitter/X, YouTube, and Instagram.

AFPRAL's business model is that of a membership-driven non-profit. Revenue is generated through annual membership fees and institutional grants and sponsorships from a roster of pharmaceutical and life sciences partners (ALK, Stallergènes Greer, Bioprojet, ThermoFisher, DBV Technologies, and Viatris Medical). Go-to-market is community-led and direct-to-consumer, combining membership campaigns, donation appeals, volunteer recruitment, public education events (including hospital stands in Lyon, Paris, and Marseille during World Allergy Week), social media engagement, and webinars. The association does not disclose pricing publicly, and there are no disclosed funding rounds, headcount figures, or revenue figures in the available data.

Name

Association Française Pour La Prévention Des Allergies

Legal name

Association Française pour la Prévention des Allergies

Website

https://afpral.fr

Company type

Private

Founded year

1991

Operating status

Operating

Headcount range

1–10 employees

Short description

AFPRAL is a French non-profit patient association that informs, supports, and represents people affected by allergies in France. It operates certification, therapeutic education, and European youth exchange programs, funded by memberships and pharmaceutical/life sciences institutional partners.

Ownership category

akta.pro rank

Headquarters

HQ city

Paris

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Membership fees: AFPRAL generates revenue through annual membership fees from its members who join to support the association and access its resources and services.
2. Institutional grants and sponsorships: The association receives support from pharmaceutical and medical companies including Bioprojet, Viatris, and ALK as institutional partners, providing financial backing for its mission and activities.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels9 records

Core offering

AFPRAL is a French non-profit patient association that informs, supports, and represents people affected by allergies. It delivers therapeutic education programs, runs the "Distingué par l'AFPRAL" product/service certification, publishes Allergie Le Mag, organizes community events and surveys, and advocates for allergy patients with national authorities.

Product overview

AFPRAL operates as a patient advocacy association focused on allergy prevention, awareness, and support rather than as a technology company. Its portfolio centers on the 'Distingué par l'AFPRAL' product certification program, educational publications (Allergie Le Mag magazine), therapeutic education services for patients, and community initiatives such as the European 'Beyond the Label' youth exchange project and national pollen allergy surveys. The association also provides informational webinars and resources for managing allergies in schools, workplaces, and travel situations. As a nonprofit organization, AFPRAL does not offer a SaaS platform or API-based products; its digital presence is built on the AssoConnect association management platform.

Differentiator

Problem solved

Functional benefit

Products and services

• Distingué par l'AFPRAL (Distinguished by AFPRAL)

Quantifiable outcome

• 18 million French people benefit from allergy awareness and prevention efforts
• +1 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Nine partnerships are on record, tiered core and flagship.

• ALKcoreStrategic or Co-development PartnerALK is a pharmaceutical company specializing in allergy treatments and is one of AFPRAL's institutional partners, supporting the association's mission to prevent allergies and improve patient care.
• Stallergènes GreercoreStrategic or Co-development PartnerStallergènes Greer is a global leader in allergy immunotherapy and an institutional partner of AFPRAL, collaborating on allergy awareness and patient support initiatives.
• BioprojetcoreStrategic or Co-development PartnerBioprojet is a pharmaceutical company and institutional partner supporting AFPRAL's activities, including educational programs and the annual World Allergy Week campaign.
• ThermoFisher ScientificcoreStrategic or Co-development PartnerThermoFisher Scientific is an institutional partner of AFPRAL, contributing to the association's mission through financial and organizational support.
• DBV TechnologiescoreStrategic or Co-development PartnerDBV Technologies develops Viaskin Peanut for peanut allergy treatment and is an institutional partner of AFPRAL, sponsoring events and educational programs.
• Viatris MedicalcoreStrategic or Co-development PartnerViatris Medical is an institutional partner supporting AFPRAL's World Allergy Week activities and patient education initiatives.
• AEPNAA (Spain)flagshipStrategic or Co-development PartnerAEPNAA is a Spanish patient association and partner in the Beyond the Label ERASMUS+ project, bringing together young allergic people from France, Spain, Italy, and Sweden.
• Unga Allergiker (Sweden)flagshipStrategic or Co-development PartnerUnga Allergiker is a Swedish patient association and partner in the Beyond the Label ERASMUS+ project, supporting youth with food allergies across Europe.
• Food Allergy Italia (Italy)flagshipStrategic or Co-development PartnerFood Allergy Italia is an Italian patient association and partner in the Beyond the Label ERASMUS+ project, collaborating with AFPRAL on European youth exchanges.

Scale indicators9 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Allergy UK: UK-based national allergy patient charity providing information, support, and advocacy for people with allergies. Directly comparable to AFPRAL as a country-level patient advocacy organization addressing the same condition class with similar service mix.
• Food Allergy Italia: Italian food allergy patient association and Beyond the Label ERASMUS+ partner of AFPRAL. Directly comparable as a country-level food allergy advocacy peer with parallel school inclusion and patient education activities.
• Food Allergy Research & Education (FARE): US national non-profit focused on food allergy advocacy, education, and research funding. Directly comparable to AFPRAL on mission scope (food allergy subset), advocacy activities, school inclusion programs, and institutional sponsor mix.
• Asthma and Allergy Foundation of America (AAFA): US patient advocacy non-profit covering asthma and allergies with certification programs and policy advocacy. Directly comparable to AFPRAL on combined asthma-allergy scope, certification offerings, and patient education focus.
• AEPNAA (Asociación Española de Personas con Alergia a Alimentos y Látex): Spanish food and latex allergy patient association and a Beyond the Label ERASMUS+ partner of AFPRAL. Directly comparable as a country-level food allergy advocacy peer with similar programs and youth engagement focus.
• Unga Allergiker: Swedish patient association for young people with allergies and a Beyond the Label ERASMUS+ partner of AFPRAL. Directly comparable as a peer patient advocacy body with focus on youth allergy populations.

Broad incumbents

• European Federation of Allergy and Airways Diseases Patients' Associations (EFA): Pan-European umbrella organization coordinating allergy and respiratory disease patient associations across EU member states. Comparable as a higher-tier umbrella that AFPRAL could partner with or be absorbed by, operating in the same advocacy space at broader geographic scope.

Regional players

• Allergies Québec: Canadian (Quebec) patient association focused on food and environmental allergies with information, support, and advocacy mandates. Comparable as a French-language regional patient advocacy peer with similar information, education, and community mobilization offerings.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks4 records

Key highlights6 records

Customer concentration

• Xx.com/afpral
• YouTubeyoutube.com/channel/UC2aE4Us3E5VUfGf0EPrPEcg
• Facebookfacebook.com/AFPRAL
• Instagraminstagram.com/afpral_allergies

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Association Française Pour La Prévention Des Allergies